Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
49 results about "Cervical lymph nodes" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Cervical lymph nodes are lymph nodes found in the neck. Of the 800 lymph nodes in the human body, 300 are in the neck. Cervical lymph nodes are subject to a number of different pathological conditions including tumours, infection and inflammation.
Cervical lymph node ultrasonoscopy feature selection method
ActiveCN103593674AFast convergenceImprove classification accuracyCharacter and pattern recognitionLearning machineImaging processing
The invention discloses a cervical lymph node ultrasonoscopy feature selection method, and relates to the technical field of image processing. The technical problem needing to be solved is that the genetic algorithm and the dispersing particle swarm optimization are easily caught in the local extremum when the genetic algorithm and the dispersing particle swarm optimization are utilized for carrying out cervical lymph node ultrasonoscopy feature selection. According to the technical scheme, the method comprises the first step of collecting and extracting the quantization feature of a cervical lymph node image, the second step of forming a sample set, the third step of designing an extremity learning machine classifier, the fourth step of learning and training the sample set, the fifth step of calculating the accelerated speed of each individual, the sixth step of updating the respective speed, the seventh step of calculating the respective Boltzmann function, the eighth step of updating the respective position and the ninth step of terminating the process and outputting the optimal position, namely, the optimal character subset if the end condition is met, or otherwise, adding iteration with 1 and carrying out the third step to continue evolving the population until the end condition is met. The cervical lymph node ultrasonoscopy feature selection method is suitable for helping doctors to select valuable cervical lymph node ultrasonoscopy features.
Owner:TAIYUAN UNIV OF TECH
Construction of live attenuated Shigella vaccine strains that express CFA/I antigens (cfaB and CfaE) and the B subunit of heat-labile enterotoxin (LTB) from enterotoxigenic E.coli
ActiveUS20070237791A1Reduce intrusionBacterial antigen ingredientsBacteriaHeterologousMucosal Immune Responses
With the goal of creating a combination vaccine against Shigella and other diarrheal pathogens we have constructed a prototype vaccine strain of Shigella flexneri 2a (SC608) that can serve as a vector for the expression and delivery of heterologous antigens to the mucosal immune system. SC608 is an asd derivative of SC602, a well-characterized vaccine strain, which has recently undergone several phase 1 and 2 trials for safety and immunogenicity. Using non-antibiotic asd-based plasmids, we have created novel constructs for the expression of antigens from enterotoxigenic E. coli (ETEC), including CFA / I (CfaB and CfaE) and the B-subunit from heat-labile enterotoxin (LTB) in Shigella vaccine strain SC608. Heterologous protein expression levels and cellular localization are critical to immune recognition and have been verified by immunoblot analysis. Following intranasal immunization (SC608(CFAI) and SC608(CFAI / LTB) of guinea pigs, serum IgG and IgA immune responses to both the Shigella LPS and ETEC antigens can be detected by ELISA. In addition, ELISPOT analysis for ASCs from cervical lymph nodes and spleen showed similar responses. All vaccine strains conferred high levels of protection against challenge with wild-type S. flexneri 2a using the Sereny test. Furthermore, serum from guinea pigs immunized with SC608 expressing CfaB and LTB contained antibodies capable of neutralizing the cytological affects of heat-labile toxin (HLT) on Chinese Hamster Ovary (CHO) cells. These initial experiments demonstrate the validity of a multivalent invasive Shigella strain that can serve as a vector for the delivery of pathogen-derived antigens.
Owner:UNITED STATES OF AMERICA THE AS REPRESENTED BY THE SEC OF THE ARMY
Antigen covalently bound chitosan nanoparticle-based nasal immune carrier
ActiveCN104274830ANot easy to fall offOvercoming the disadvantages of encapsulating antigensCarrier-bound antigen/hapten ingredientsPharmaceutical non-active ingredientsTumor-Related ProteinDisease
The invention belongs to the technical field of medicines, and relates to an antigen covalently bound chitosan nanoparticle-based nasal immune carrier and a preparation method thereof. The carrier is composed of a nanoparticle and an antigen, the antigen is covalently bound to the surface of the nanoparticle, and the nanoparticle is prepared by adopting a raw material chitosan and its derivatives; and the antigen is selected from from infectious diseases or tumors related proteins or polypeptides. The carrier can significantly improve the neck lymph node targeting of people nasally dosed with the antigen proteins or polypeptides, enhances the mucosal and systemic immune response, has the advantages of simple preparation, stable process, high antigen utilization rate, difficult antigen shedding, benefiting of the improvement of the cervical lymph node transportation of the antigens, good nasal immune effect and no nasal mucosa toxicity, and is suitable for preventing respiratory infectious diseases.
Owner:FUDAN UNIV
Biological marker of oral cavity oropharynx squamous-cell carcinoma and application of biological marker
ActiveCN104267191AIncreased sensitivityImprove featuresDisease diagnosisBiological testingLymphatic SpreadSmall-cell carcinoma
The invention provides a biological marker of oral cavity oropharynx squamous-cell carcinoma and application of the biological marker. The biological marker is GPD1L and / or HIF1 alpha, and especially a combination of the GPD1L and the alpha. According to the invention, by detecting expression levels of the GPD1L and / or the HIF1 alpha, oral cavity oropharynx squamous-cell carcinoma auxiliary diagnosis, oral cavity oropharynx squamous-cell carcinoma patient prognosis, and / or prognosis cervical lymph node metastasis prediction can be performed.
Owner:PEKING UNIV SCHOOL OF STOMATOLOGY
Triple compound microsphere vascular targeted embolization sustained-release preparation containing antituberculous drug as well as preparation method and application of preparation
ActiveCN104324032AExcellent anti-tuberculosis effect in vitro and in vivoReduce concentrationAntibacterial agentsOrganic active ingredientsAntituberculous drugHemoptyses
The invention relates to a triple compound microsphere vascular targeted embolization sustained-release preparation containing an antituberculous drug as well as a preparation method and application of the preparation. The sustained-release agent comprises a carrier and drugs, wherein the drugs are coated with the carrier; the carrier is sodium alginate or chitosan, and the drugs are triple antituberculous compound drugs including rifampicin, isoniazid and pyrazinamide or moxifloxacin. The three antituberculous drugs are matrix drug solutions, the sodium alginate or chitosan is a carrier solution, the matrix drug solutions and the carrier solutiona are mixed to prepare a solution, the polymer solution containing drugs is dispersed into fogdrops with a certain diameter by adopting a high-voltage electrostatic droplet mode, and the fogdrops are sprayed into a solidifying liquid to prepare antituberculous drug microspheres under the action of calcium ions. The embolization sustained-release preparation can be used for treating tuberculosis, massive hemoptysis of pulmonary tuberculosis, tuberculosis cavity, renal tuberculosis, osteoarticular tuberculosis, genital tuberculosis, tuberculosis of thyroid gland, tuberculosis of cervical lymph nodes, tuberculosis of pericardium, tuberculosis of chest wall, pleural tuberculosis and other kinds of tuberculosis in a body.
Owner:THE 309TH HOSPITAL OF CHINESE PEOPLES LIBERATION ARMY +1
Method for establishing model of oral cancer and lymphatic metastasis of mice
InactiveCN102599106ADiverse disease sitesThe method is simpleHeterocyclic compound active ingredientsAnimal husbandryBALB/cDisease
The invention discloses a method for establishing a model of oral cancer and lymphatic metastasis of mice, which is characterized by including mouse selection and grouping, reagent preparation, mouse feeding, experimental observation and conclusion drawing. The method specifically includes: using 200mg / L 4-nitroquinoline-1-oxide to feed Balb / c (Bagg albino / c) mice for 20 weeks by a drinking method; continuously using tap water to feed the mice to the fortieth week and observing to the fortieth week; obtaining the model of oral cancer and lymphatic metastasis of the mice which have development metastasis extremely similar to human oral cancer, namely location diversification, a full metastasis process of normal mucosa, dysplasia, carcinoma in situ, squamous carcinoma and cervical lymph nodes. The method is simple, natural and ideal in effect, guarantees high morbidity, diversified disease locations (lip, palate, gum, tongue and mouth floor) and high submandibular lymph node metastasis rate, and a novel powerful tool for preventing and treating human oral cancer is provided.
Owner:GUANGXI MEDICAL UNIVERSITY
Medicine capable of treating tuberculosis and osteomyelitis
ActiveCN103877460AGood effectEasy dischargeAntibacterial agentsAnthropod material medical ingredientsCentipedeSide effect
The invention discloses a medicine capable of treating tuberculosis and osteomyelitis. A preparation method of the medicine comprises the steps of grinding baked dinodon rufozonatum, baked centipede, astragalus membranaceus, angelica sinensis, scutellaria baicalensis, dangshen, bighead atractylodes rhizome, angelica dahurica, radix stemonae, honeysuckle, radix rehmanniae, liquorice, radix cyathulae and poria cocos into fine powder, mixing, and refining into pills by using honey. The medicine has an obvious treatment effect on pulmonary tuberculosis, pleurisy, osteoarticular tuberculosis, tuberculosis of cervical lymph nodes, osteomyelitis and the like. After the tuberculosis of cervical lymph nodes ruptures, a thread covered with dinodon rufozonatum powder is inserted into the tuberculosis of cervical lymph nodes, and the medicine has internal and external treatment effects; after sinus tracts form in an osteomyelitis patient, the thread covered with the dinodon rufozonatum powder is inserted into the tracts, fester can be quickly discharged, sequestrum automatically comes off, and osteotrauma automatically repairs to recovery. The medicine does not increase the surgery pain of patients, has no side effects and does not cause serious allergy or damage internal organs after long-term taking; the medicine only needs to be taken at home, and holed cauterized needling can be applied in small clinics, so that the medicine expenses are small. The curative ratio of the tuberculosis diseases is above 99%, and the curative ratio of the osteomyelitis is above 90%.
Owner:匡敬哲
Construction of live attenuated Shigella vaccine strains that express CFA/I antigens (CfaB and CfaE) and the B subunit of heat-labile enterotoxin (LTB) from enterotoxigenic E. coli
ActiveUS7759106B2Reduce intrusionBacterial antigen ingredientsBacteriaHeterologousMucosal Immune Responses
Owner:UNITED STATES OF AMERICA THE AS REPRESENTED BY THE SEC OF THE ARMY
Novel application of rapid immunodetection system to operation
PendingCN108089011AEasy to operateDisease diagnosisBiological testingLymphatic SpreadRegion lymph node
The invention discloses novel application of a rapid immunodetection system to an operation. According to the novel application of the rapid immunodetection system to the operation, whether cervical lymph node metastasis of thyroid cancer exists or not is identified by detecting the content of thyroglobulin. The novel application of the rapid immunodetection system in the operation comprises the following specific operation steps that a, tissues of regional lymph nodes of a thyroid are punctured; b, an eluent for puncturing the tissues is prepared; c, quantitative detection treatment of the thyroglobulin (TG) is directly carried out on the prepared eluent through the rapid immunodetection system; and d, whether thyroid cancer metastasis of the regional lymph nodes exists or not is identified according to the TG detection result obtained by the rapid immunodetection system, wherein in the step c, the eluent is dripped to TG test paper, then the detection line and the quality control line on the TG test paper are scanned through a detector of the immunodetection system, and parameter calculation treatment is carried out through a processing unit arranged inside the detector so as toobtain the content of the thyroglobulin (TG) in the tissues. The novel application of the rapid immunodetection system to the operation has the characteristics of being convenient and rapid to operate, and operation can be directly performed beside an operating table during operation.
Owner:GUANGZHOU KANGRUN BIOTECHNOLOGY CO LTD
Marker for thyroid cancer diagnosis, stratification and prognosis and application thereof
PendingCN114487417AEasy to detectShort timeComponent separationOrgan movement/changes detectionOncologyNeck lymph nodes
Owner:PEKING UNION MEDICAL COLLEGE HOSPITAL CHINESE ACAD OF MEDICAL SCI
Vascular targeting embolism sustained release agent of triple compound microsphere for antituberculosis drug, preparation method and applications thereof
ActiveCN102670611AExcellent anti-tuberculosis effect in vitro and in vivoReduce concentrationAntibacterial agentsOrganic active ingredientsDrugs solutionAntituberculosis drug
The invention relates to a vascular targeting embolism sustained release agent of a triple compound microsphere for an antituberculosis drug, a preparation method and applications thereof. The sustained release agent comprises a carrier and a drug, wherein the drug is encapsulated by the carrier, the carrier is selected from sodium alginate or chitosan, and the drug is a triple compound antituberculosis drug which comprises rifampin, isoniazide and pyrazinamide or moxifloxacin. Three antituberculosis drugs are employed as matrixes of a drug solution, sodium alginate or chitosan is used as a carrier solution, and a prepared solution is obtained by mixing the drug solution and the carrier solution. A polymer solution having the drug is enabled to be dispersed into droplets with certain particle sizes and to be sprayed into a curing liquid through a method of high voltage electrostatic droplets, and thus the microsphere for the antituberculosis drug are prepared in the presence of calcium ions. The embolism sustained release agent can be used in the drug for treating pulmonary tuberculosis, pulmonary tuberculosis massive hemoptysis, cavitary pulmonary tuberculosis, renal tuberculosis, osteoarticular tuberculosis, genital tubercolosis, thyroid tuberculosis, tuberculosis of cervical lymph nodes, pericardial tuberculosis, chest-wall tuberculosis and other in-vivo tuberculosises.
Owner:THE 309TH HOSPITAL OF CHINESE PEOPLES LIBERATION ARMY +1
Traditional Chinese medicine for treating cervical lymph node tuberculosis
InactiveCN103845592AQuick resultsGood curative effectAntibacterial agentsInorganic active ingredientsTraditional medicinePericarpium citri reticulatae
The invention relates to a traditional Chinese medicine for treating cervical lymph node tuberculosis. The traditional Chinese medicine disclosed by the invention is prepared from radix bupleuri, Chinese angelica, radix paeoniae alba, selfheal, pericarpium citri reticulatae, thunberg fritillary bulb, radix scrophulariae, oyster, kelp, seaweed, bryozoatum, trichosanthes kirilowii maxim, platycodon grandiflorum and fructus aurantii. When in use, 700 ml of water is added into the first dose of the medicines so as to decoct to 200 ml; 500 ml of water is added into the second dose of the medicines so as to decoct to 200 ml; the traditional Chinese medicine is taken for two times in morning and evening on an empty stomach every day.
Owner:马芳
Nose suppository for treating tuberculosis of cervical lymph nodes
InactiveCN101342252ACause disappearPromote healingAntibacterial agentsSuppositories deliveryDiseaseSide effect
The present invention relates to a buginaria which is used for remedying the tuberculosis of cervical lymph node. The buginaria is prepared from croton, white mustard seed, pangolin, coptis and red jujube. The invention uses meridians and collaterals to transmit drug efficacy by nose-plugging manner according to the traditional medical theory of wholism concept and dialectic treatment, the exterior and interior relation of Zang-fu viscera and meridians and the meridian tropism performance of the four properties and five tastes of Chinese medicine. Without influencing job and life of patients, the invention can heal the tuberculosis of cervical lymph node in 4 to 6 times with the advantages of quick treatment effect, short treatment course, no pain and recrudescence, high cure rate, no toxic and side effect, simple use method and good effect. The invention has the functions of removing wetness and sputum, promoting blood circulation by removing blood stasis, dredging meridians, trimming bruise, stopping pain, converging ulcer, growing muscle and regulating internal mechanism. If meridians are clear, tuberculosis disappears automatically. The symptoms and the root causes of disease are remedied. Compared with the prior art, the invention has more active effect.
Owner:毋乃祯
Traditional Chinese medicine composition for treating tuberculosis of cervical lymph nodes
InactiveCN102579774BUnique curative effectGood absorption and dispersionAntibacterial agentsMolluscs material medical ingredientsSalvia miltiorrhizaHouttuynia
The invention discloses a traditional Chinese medicine composition for treating tuberculosis of cervical lymph nodes. The traditional Chinese medicine composition is characterized by comprising the following traditional Chinese medicine raw materials in parts by weight: 25-35 parts of common selfheal fruit-spike, 25-35 parts of ternate buttercup root, 25-35 parts of raw oyster, 10-20 parts of radix salviae miltiorrhizae, 10-20 parts of kelp, 10-20 parts of seaweed, 5-15 parts of honeysuckle, 5-15 parts of dandelion, 5-15 parts of wild chrysanthemum flower, 5-15 parts of Chinese thorowax root,5-15 parts of Chinese angelica, 5-15 parts of white paeony root, 5-15 parts of tuber pinellia, 5-15 parts of dried orange peel, 5-15 parts of nutgrass galingale rhizome, 5-15 parts of baical skullcaproot, 3-9 parts of fewflower lysionotus, 3-9 parts of ordate houttuynia, 3-9 parts of longstamen onion bulb, 3-9 parts of herba hyperici, 1-5 parts of radix semiaquilegiae and 1-5 parts of climbing nightshade. The traditional Chinese medicine composition disclosed by the invention has the advantages of expelling stagnation, reducing phlegm, attacking and supplementing at the same time, soothing liver, relieving stagnation, reducing phlegm, removing stasis and realizing special efficacy.
Owner:李永泉
Thyroid nodule risk prediction method and system based on big data
InactiveCN108962387AQuick extractionRapid Risk PredictionHealth-index calculationUltrasonic attenuationNeck lymph nodes
The invention discloses a thyroid nodule risk prediction method and system based on big data. The method comprises following steps of S1: acquisition of clinic data: collecting data of medical histories, signs and symptoms of a patient and recording the data; S2: ultrasonic examination: carrying out thyroid nodule checking of the patient, knowing the size, the shape, the nodule edge, the inner structure, the echo features, the blood flow conditions and the cervical lymph node conditions of the nodule; and S3: fine needle aspiration examination: carrying out thyroid nodule fine needle aspiration cytological examination on the patient, checking result data and carrying out recording. According to the invention, by acquiring clinic data of the patient, carrying out the ultrasonic examinationand the fine needle aspiration examination on the patient, and integrating the examination data, rapid extraction of the data is facilitated and risk prediction can be rapidly made.
Owner:THE FIRST AFFILIATED HOSPITAL OF JINAN UNIV
Vascular targeting embolism sustained release agent of triple compound microsphere for antituberculosis drug, preparation method and applications thereof
ActiveCN102670611BExcellent anti-tuberculosis effect in vitro and in vivoReduce concentrationAntibacterial agentsOrganic active ingredientsDrugs solutionAntituberculosis drug
The invention relates to a vascular targeting embolism sustained release agent of a triple compound microsphere for an antituberculosis drug, a preparation method and applications thereof. The sustained release agent comprises a carrier and a drug, wherein the drug is encapsulated by the carrier, the carrier is selected from sodium alginate or chitosan, and the drug is a triple compound antituberculosis drug which comprises rifampin, isoniazide and pyrazinamide or moxifloxacin. Three antituberculosis drugs are employed as matrixes of a drug solution, sodium alginate or chitosan is used as a carrier solution, and a prepared solution is obtained by mixing the drug solution and the carrier solution. A polymer solution having the drug is enabled to be dispersed into droplets with certain particle sizes and to be sprayed into a curing liquid through a method of high voltage electrostatic droplets, and thus the microsphere for the antituberculosis drug are prepared in the presence of calcium ions. The embolism sustained release agent can be used in the drug for treating pulmonary tuberculosis, pulmonary tuberculosis massive hemoptysis, cavitary pulmonary tuberculosis, renal tuberculosis, osteoarticular tuberculosis, genital tubercolosis, thyroid tuberculosis, tuberculosis of cervical lymph nodes, pericardial tuberculosis, chest-wall tuberculosis and other in-vivo tuberculosises.
Owner:THE 309TH HOSPITAL OF CHINESE PEOPLES LIBERATION ARMY +1
Chinese herbal medicine for treating tuberculosis of cervical lymph nodes
InactiveCN102327347AEffective treatmentNo side effectsAntibacterial agentsPlant ingredientsBarbed Skullcap HerbPharmaceutical drug
The invention discloses a Chinese herbal medicine for treating tuberculosis of cervical lymph nodes. The Chinese herbal medicine is prepared from the following medicines in parts by weight: 10-20 parts of Japanese metaplexis, 10-20 parts of semiliquidambar cathayensis, 40-60 parts of humata repens roots, 20-30 parts of herba chloranthi serrati, 20-30 parts of ixora chinensis and 20-30 parts of barbed skullcap herb. The Chinese herbal medicine is prepared by adding 1000 parts by weight of water, after the water is boiled, decocting the medicines with slow fire for 20-30 minutes, filtering the decoction and collecting the supernatant, decocting the supernatant three times, bottling and uniformly mixing the supernatant decocted three times and then sterilizing the supernatant under a high temperature for later use. The compatibility thought is as follows: Japanese metaplexis is taken as the monarch, semiliquidambar cathayensis and humata repens roots are taken as the ministers, herba chloranthi serrati and ixora chinensis are taken as the assistants, and barbed skullcap herb is taken as the guide. The Chinese herbal medicine has the following beneficial effects: the Chinese herbal medicine is convenient to prepare and use, is safe, does not have side effects, eliminates phlegm and cools blood, has an obvious effect on treating tuberculosis of cervical lymph nodes and has the function of treating both the secondary and primary symptoms.
Owner:CHONGQING NANCHUAN DISTRICT RUIFENG AGRI DEV
Traditional Chinese medicine for treating cervical lymph node
InactiveCN103768527AGood curative effectShort course of treatmentAntibacterial agentsPlant ingredientsCissus discolorViola yedoensis
The invention relates to the field of traditional Chinese medicinal preparations, and particularly relates to a traditional Chinese medicine for treating cervical lymph node. The traditional Chinese medicine is characterized by comprising the following raw medicinal materials in weight percentage: 11-14% of immature bitter orange, 6-9% of dandelion, 4-6% of artemisia annua, 6-9% of dysosma versipellis, 3-5% of callicarpa formosana roots, 11-14% of belamcanda chinensis, 3-5% of lonicera japonica stem, 6-9% of Lysimachia fortunei, 2-3% of fringed pink, 4-6% of dendrobe, 3-5% of viola yedoensis, 4-6% of lycopodium japonicum, 4-7% of radix curcumae, 6-8% of dioscorea bulbifera rhizome, 2-4% of cissus discolor stem, and 3-5% of Platycodon grandiflorum. A preparation method of the traditional Chinese medicine comprises the following steps of soaking the above raw materials in water, decocting, removing residue, and collecting filtrate. The traditional Chinese medicine disclosed by the invention has a high therapeutic effect on cervical lymph node, and is low in cost, short in treatment course and free of recurrence.
Owner:赵文革
Method for analyzing cervical lymph node metastasis, and tumor marker for head and neck cancer
InactiveUS20120270218A1Sugar derivativesMicrobiological testing/measurementLymphatic SpreadGynecology
Provided are a method for analyzing metastasis of head and neck cancer to a cervical lymph node, and a tumor marker for head and neck cancer used therein. Specifically, provided is a method for analyzing metastasis of head and neck cancer to a cervical lymph node, involving: measuring an expression level of at least one gene selected from the group consisting of genes represented by SEQ ID NOS: 1 to 36 in the sequence listing in a cervical lymph node sample; and comparing the aforementioned expression level with a reference value. Also provided is a tumor marker for head and neck cancer used in the aforementioned method for analyzing cervical lymph node metastasis, including at least one gene selected from the group consisting of genes represented by SEQ ID NOS: 1 to 36 in the sequence listing, and / or an expression product of the aforementioned gene and / or an expression level thereof.
Owner:NAT UNIV CORP EHIME UNIV
Method for establishment of tumor lymph node high-metastasis model and rapid fluorescence detection
InactiveCN109010366ASolve the distinctionMammal material medical ingredientsIn-vivo testing preparationsAbnormal tissue growthMetabolite
The invention discloses a method for establishing a model of a large animal tumor lymph node high-metastasis model and rapidly detecting the lymph node containing tumor cells in real time. The methodcomprises the following steps: establishing a rabbit tongue tumor model, and establishing a rabbit cervical lymph node high-metastasis model based on the rabbit tongue tumor model; after successful establishment of the rabbit cervical high-metastasis model, an endogenous substance 5-aminolevulinic acid (5-ALA) is used, and the fluorescence of its metabolite protoporphyrin (PPIX) is used to rapidlyand accurately detect the rabbit cervical lymph node. The method has the advantages of simple operation and high reliability, fully and completely simulates the clinical characteristics and biological characteristics of human tongue cancer lymph node metastasis, provides a research model for the treatment and resection of lymph node metastasis of human tumors, provides a novel means for intraoperative visualization of real-time tumor lymph node dissection, and has broad application prospects in the fields of biomedical and photodynamic diagnosis.
Owner:NANJING UNIV
Medicine for treating tuberculosis of cervical lymph nodes, cyclomastopathy and mumps
ActiveCN102526440ARelieve painPromote absorptionAmphibian material medical ingredientsAntibacterial agentsTreating tuberculosisMammary gland
The invention discloses a medicine for treating tuberculosis of cervical lymph nodes, cyclomastopathy and mumps. The medicine is prepared by using the following raw materials by weight part: 4-5 parts of Chinese alangium leaves, 5-8 parts of omoto nipponlily roots, 8-10 parts of rumex madaio, 4-5 parts of Paris rhizomes, 8-10 parts of pokeberry roots, 4-5 parts of radix semiaquilegiae, 8-10 partsof dysosma versipellis and 3-4 parts of toads. A preparation method for the medicine provided by the invention comprises the following steps: weighting all the raw materials by weight part, washing the raw materials and then drying at the temperature below 35 DEG C; milling the raw materials into fine powder and screening by using a 100 mesh sieve; adding 60%-70% alcohol into the powder, wherein the weight of the alcohol is 3-4 times of the total weight of the powder; mixing and soaking for 5-7 days; removing the alcohol; and adding a suitable amount of honey and preparing into paste for externally applying. The medicine provided by the invention has the advantages that only few medicines are externally applied; the pains of a patient caused by taking medicines, injection and surgery are avoided; the application scope is wide; and the medicine is easily absorbed, quickly becomes effective, is high in cure rate, is low in cost and is free from side effect.
Owner:唐启裕
A traditional Chinese medicine preparation for treating cervical lymph node enlargement after respiratory tract infection in children
InactiveCN104644814BStrong anti-infection abilityShort treatment cycleHydroxy compound active ingredientsAntiinfectivesSide effectModern medicine
The invention discloses a traditional Chinese medicine preparation for treating enlargement of cervical lymph nodes after respiratory tract infection in children. The traditional Chinese medicine preparation is prepared from the following raw materials in parts by weight: 28-32g of dandelion, 28-32g of wild chrysanthemum flower, 28-32g of cottonrose hibiscus leaf, 28-32g of oldenlandia diffusa, 13-17g of scutellaria baicalensis, 8-12g of flos carthami, 8-12g of radix angelicae dahuricae, 18-22g of gardenia, 3-7g of rheum officinale and 0.3-0.7g of borneol. The selected medicinal materials for the traditional Chinese medicine preparation are appropriate in compatibility, and conform with the research theories of the traditional Chinese medicine and the modern medicine, so that the traditional Chinese medicine preparation has the characteristics of being short in treatment cycle, convenient to use, free of pain, free of a toxic or side effect, fast in acting, low in cost and the like. Through clinical verification, the recovery rate can be up to 96%; the curative effect is good; and the traditional Chinese medicine preparation only needs to be attached to the swollen lymph part of a patient, so that the traditional Chinese medicine preparation can be popularized and applied.
Owner:QIANFOSHAN HOSPITAL OF SHANDONG
Medicine for treating tuberculosis of cervical lymph nodes, cyclomastopathy and mumps
ActiveCN102526440BRelieve painPromote absorptionAntibacterial agentsAmphibian material medical ingredientsAlcohol ethylPharmaceutical drug
The invention discloses a medicine for treating tuberculosis of cervical lymph nodes, cyclomastopathy and mumps. The medicine is prepared by using the following raw materials by weight part: 4-5 parts of Chinese alangium leaves, 5-8 parts of omoto nipponlily roots, 8-10 parts of rumex madaio, 4-5 parts of Paris rhizomes, 8-10 parts of pokeberry roots, 4-5 parts of radix semiaquilegiae, 8-10 parts of dysosma versipellis and 3-4 parts of toads. A preparation method for the medicine provided by the invention comprises the following steps: weighting all the raw materials by weight part, washing the raw materials and then drying at the temperature below 35 DEG C; milling the raw materials into fine powder and screening by using a 100 mesh sieve; adding 60%-70% alcohol into the powder, wherein the weight of the alcohol is 3-4 times of the total weight of the powder; mixing and soaking for 5-7 days; removing the alcohol; and adding a suitable amount of honey and preparing into paste for externally applying. The medicine provided by the invention has the advantages that only few medicines are externally applied; the pains of a patient caused by taking medicines, injection and surgery are avoided; the application scope is wide; and the medicine is easily absorbed, quickly becomes effective, is high in cure rate, is low in cost and is free from side effect.
Owner:唐启裕
Prediction method for benign and malignant cervical lymph nodes before minimal thyroid cancer ablation
PendingCN113223716AHelps make accurate decisionsAccurate prediction of benign and malignantImage enhancementImage analysisLymph node regionsOncology
The invention discloses a method for predicting benign and malignant cervical lymph nodes before a minimal thyroid carcinoma ablation operation, which overcomes the defects of lack of specificity, lower diagnosis accuracy and limitation in preoperative judgment of minimal thyroid carcinoma cervical lymph node metastasis by the conventional imaging method at present. The method is characterized by comprising the following steps: S1, acquiring a gray-scale ultrasonic image of a neck lymph node before a thyroid minimal cancer minimally invasive ablation operation; s2, performing ROI outlining and segmentation on a lymph node region in the image; s3, performing image matching and high-throughput feature extraction, and calculating omics features; s4, carrying out feature dimension reduction; s5, establishing a radiomics prediction model, and performing external verification of the model; s6, inputting the ultrasonic image into a radiomics prediction model for prediction and outputting a prediction result. The method for predicting benign and malignant cervical lymph nodes before minimal thyroid cancer ablation can meet clinical diagnosis and treatment requirements, can establish the prediction model for accurate prediction, and can assist in clinical accurate decision making.
Owner:上海奥创安可塔医疗科技有限公司
Method of predicting metastasis of oral cavity cancer into cervical lymph node and diagnosis kit to be used in the prediction
InactiveUS20090317813A1Sugar derivativesMicrobiological testing/measurementStage iibLymphatic Spread
A method for objectively predicting possibility of metastasis to a cervical lymph node in an early stage for an individual case diagnosed as an oral cavity cancer, and a diagnosis kit to be used in the prediction are provided. The method includes a step of assaying expression amounts of metastasis prediction genes in which the expression amounts are changed between a metastasis group and a non-metastasis group, with respect to a sample collected from a primary legion of the oral cavity cancer. Further, the method includes a step of predicting the possibility of the metastasis by comparing the expression amounts of the metastasis gene group with the expression amounts of the metastasis prediction genes in a metastasis group and / or a non-metastasis group. Herein, the metastasis prediction gene group includes two genes MSR1 (NM_138716.1) and RET (M31213.1).
Owner:NAT INST OF RADIOLOGICAL SCI
Markers and their applications for the diagnosis, stratification and prognosis of thyroid cancer
ActiveCN113311079BEasy to detectShort timeAnalysing fluids using sonic/ultrasonic/infrasonic wavesComponent separationNode metastasisThyroid gland cancer
Owner:PEKING UNION MEDICAL COLLEGE HOSPITAL CHINESE ACAD OF MEDICAL SCI
A Feature Selection Method for Ultrasound Image of Cervical Lymph Nodes
ActiveCN103593674BFast convergenceImprove classification accuracyCharacter and pattern recognitionSonificationAlgorithm
The invention relates to a method for selecting features of ultrasound images of cervical lymph nodes, which relates to the technical field of image processing; the technical problem to be solved is to avoid the problem that the selection of features of ultrasound images of cervical lymph nodes by using a genetic algorithm and a discrete particle swarm optimization algorithm is easy to fall into a local extremum; The technical scheme adopted is as follows: the first step is to collect and extract the quantitative features of cervical lymph node images; the second step is to form a sample set; the third step is to design an extreme learning machine classifier; the fourth step is to learn and analyze the sample set Training; the fifth step, calculate the acceleration of each individual Step 6. Update their respective speeds The seventh step is to calculate the respective Boltzmann functions Step 8. Update their respective positions The ninth step, if the termination condition is met, then end and output the optimal position, that is, the optimal feature subset, otherwise the number of iterations is increased by 1, and return to the third step to continue the evolution of the population until the termination condition is met; the present invention is suitable for helping doctors select effective Value of ultrasound image features of cervical lymph nodes.
Owner:TAIYUAN UNIV OF TECH
Biomarkers and their application in oral squamous cell carcinoma
ActiveCN104267191BIncreased sensitivityImprove featuresDisease diagnosisBiological testingNode metastasisSquamous Carcinomas
The invention provides a biological marker of oral cavity oropharynx squamous-cell carcinoma and application of the biological marker. The biological marker is GPD1L and / or HIF1 alpha, and especially a combination of the GPD1L and the alpha. According to the invention, by detecting expression levels of the GPD1L and / or the HIF1 alpha, oral cavity oropharynx squamous-cell carcinoma auxiliary diagnosis, oral cavity oropharynx squamous-cell carcinoma patient prognosis, and / or prognosis cervical lymph node metastasis prediction can be performed.
Owner:PEKING UNIV SCHOOL OF STOMATOLOGY
miRNA biomarkers and detection kits for the diagnosis of cervical lymph node metastasis in papillary thyroid carcinoma
ActiveCN113025714BTraumaEasy to detectMicrobiological testing/measurementDNA/RNA fragmentationNode metastasisSerum mirna
Owner:TONGJI HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI TECH
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com